Cargando…

Antimicrobial Susceptibility and Genetic Characterisation of Burkholderia pseudomallei Isolated from Malaysian Patients

Burkholderia pseudomallei, the causative agent of melioidosis, is intrinsically resistant to many antibiotics. Ceftazidime (CAZ), the synthetic β-lactam, is normally used as the first-line antibiotic therapy for treatment of melioidosis. However, acquired CAZ resistance can develop in vivo during tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khosravi, Yalda, Vellasamy, Kumutha Malar, Mariappan, Vanitha, Ng, Shet-Lee, Vadivelu, Jamuna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213392/ https://www.ncbi.nlm.nih.gov/pubmed/25379514 http://dx.doi.org/10.1155/2014/132971

Ejemplares similares

Host-Adaptation of Burkholderia pseudomallei Alters Metabolism and Virulence: a Global Proteome Analysis
por: Mariappan, Vanitha, et al.
Publicado: (2017)

Antimicrobial activity of Tachyplesin 1 against Burkholderia pseudomallei: an in vitro and in silico approach
por: Lee, Lyn-Fay, et al.
Publicado: (2016)

Burkholderia pseudomallei Differentially Regulates Host Innate Immune Response Genes for Intracellular Survival in Lung Epithelial Cells
por: Vellasamy, Kumutha Malar, et al.
Publicado: (2016)

Hijacking of the Host’s Immune Surveillance Radars by Burkholderia pseudomallei
por: Mariappan, Vanitha, et al.
Publicado: (2021)

Experimental Phage Therapy for Burkholderia pseudomallei Infection
por: Guang-Han, Ong, et al.
Publicado: (2016)

Altered Proteome of Burkholderia pseudomallei Colony Variants Induced by Exposure to Human Lung Epithelial Cells
por: Al-Maleki, Anis Rageh, et al.
Publicado: (2015)

OneHealth Approaches Contribute Towards Antimicrobial Resistance: Malaysian Perspective
por: Mariappan, Vanitha, et al.
Publicado: (2021)

Profiling of Burkholderia cepacia Secretome at Mid-Logarithmic and Early-Stationary Phases of Growth
por: Mariappan, Vanitha, et al.
Publicado: (2011)

Molecular evidence of Burkholderia pseudomallei genotypes based on geographical distribution
por: Zulkefli, Noorfatin Jihan, et al.
Publicado: (2016)

Survival and Intra-Nuclear Trafficking of Burkholderia pseudomallei: Strategies of Evasion from Immune Surveillance?
por: Vadivelu, Jamuna, et al.
Publicado: (2017)

Infection of Burkholderia cepacia Induces Homeostatic Responses in the Host for Their Prolonged Survival: The Microarray Perspective
por: Mariappan, Vanitha, et al.
Publicado: (2013)

Eukaryotic pathways targeted by the type III secretion system effector protein, BipC, involved in the intracellular lifecycle of Burkholderia pseudomallei
por: Kang, Wen-Tyng, et al.
Publicado: (2016)

Genomic comparison and phenotypic profiling of small colony variants of Burkholderia pseudomallei
por: Zulkefli, Noorfatin Jihan, et al.
Publicado: (2021)

Experimental exposure of Burkholderia pseudomallei crude culture filtrate upregulates PD-1 on T lymphocytes
por: Menon, Nivedita, et al.
Publicado: (2020)

Burkholderia pseudomallei type III secreted protein BipC: role in actin modulation and translocation activities required for the bacterial intracellular lifecycle
por: Kang, Wen Tyng, et al.
Publicado: (2016)

Effective Therapeutic Options for Melioidosis: Antibiotics versus Phage Therapy
por: Lim, Yue-Min, et al.
Publicado: (2022)

Zerumbone mediates apoptosis and induces secretion of proinflammatory cytokines in breast carcinoma cell culture
por: Barathan, Muttiah, et al.
Publicado: (2021)

Burkholderia vaccines: are we moving forward?
por: Choh, Leang-Chung, et al.
Publicado: (2013)

Relapse of chronic melioidosis in a paediatric cystic fibrosis patient: first case report from Malaysia
por: Mariappan, Vanitha, et al.
Publicado: (2018)

The In Vitro Antibiotic Susceptibility of Malaysian Isolates of Burkholderia pseudomallei
por: Ahmad, Norazah, et al.
Publicado: (2013)

One Health surveillance approaches for melioidosis and glanders: The Malaysian perspective
por: Mariappan, Vanitha, et al.
Publicado: (2022)

Genotypic characteristics of Uropathogenic Escherichia coli isolated from complicated urinary tract infection (cUTI) and asymptomatic bacteriuria—a relational analysis
por: Maniam, Lalitha, et al.
Publicado: (2023)

Prevalence and association of pks(+) Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia
por: Iyadorai, Thevambiga, et al.
Publicado: (2020)

The Effect of Environmental Conditions on Biofilm Formation of Burkholderia pseudomallei Clinical Isolates
por: Ramli, Nur Siti K., et al.
Publicado: (2012)

Demonstrating the utility of Escherichia coli asymptomatic bacteriuria isolates’ virulence profile towards diagnosis and management—A preliminary analysis
por: Maniam, Lalitha, et al.
Publicado: (2022)

Melioidosis in Malaysia: Incidence, Clinical Challenges, and Advances in Understanding Pathogenesis
por: Nathan, Sheila, et al.
Publicado: (2018)

Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh
por: Dutta, Subarna, et al.
Publicado: (2017)

Whole-genome comparative analysis of Malaysian Burkholderia pseudomallei clinical isolates
por: Ghazali, Ahmad-Kamal, et al.
Publicado: (2021)

Characterisation of cellular effects of Burkholderia pseudomallei cycle inhibiting factor (Cif)
por: Ng, Mei Ying, et al.
Publicado: (2018)

Enzymatic and molecular characterisation of leucine aminopeptidase of Burkholderia pseudomallei
por: Liew, Siew Mun, et al.
Publicado: (2013)

Expression of virulence and antimicrobial related proteins in Burkholderia mallei and Burkholderia pseudomallei
por: Paauw, Armand, et al.
Publicado: (2023)

Susceptibility of Clinical Isolates of Burkholderia pseudomallei to a Lipid A Biosynthesis Inhibitor
por: Sengyee, Sineenart, et al.
Publicado: (2017)

Whole-Genome Sequences of Burkholderia pseudomallei Isolates Exhibiting Decreased Meropenem Susceptibility
por: Price, Erin P., et al.
Publicado: (2017)

Phylogeography of Burkholderia pseudomallei Isolates, Western Hemisphere
por: Gee, Jay E., et al.
Publicado: (2017)

Genomic Diversity of Burkholderia pseudomallei Isolates, Colombia
por: Duarte, Carolina, et al.
Publicado: (2021)

In Vitro Susceptibility of Burkholderia pseudomallei Isolates to Cefiderocol and Ceftazidime/Avibactam from Odisha, India
por: Jena, Jayanti, et al.
Publicado: (2023)

Antimicrobial Drug–Selection Markers for Burkholderia pseudomallei and B. mallei
por: Schweizer, Herbert P., et al.
Publicado: (2008)

728. Genomic Characterization of Burkholderia pseudomallei Isolates in Colombia
por: Espitia-Acero, Catalina, et al.
Publicado: (2021)

Survival of Burkholderia pseudomallei in Water
por: Moore, Richard A, et al.
Publicado: (2008)

Detection of glycoprotein of Burkholderia pseudomallei.
por: Khrapova, N P, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_aikai19odpv6dls4vhkjf44550